Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/209337
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invite to open peer review
Title

ADCK2 Haploinsufficiency Reduces Mitochondrial Lipid Oxidation and Causes Myopathy Associated with CoQ Deficiency

AuthorsVázquez-Fonseca, Luis; Schäefer, Jochen; Navas-Enamorado, Ignacio CSIC; Santos-Ocaña, Carlos CSIC ORCID ; Hernández-Camacho, Juan Diego; Guerra, Ignacio CSIC; Cascajo Almenara, M. V. CSIC ORCID; Sánchez-Cuesta, Ana CSIC ORCID; Horvath, Zoltan; Siendones, Emilio CSIC; Jou, Cristina; Casado, Mercedes; Gutierrez-Rios, Purificacion CSIC; Brea-Calvo, Gloria CSIC ORCID; López-Lluch, Guillermo CSIC ORCID CVN ; Fernández-Ayala, Daniel J. M.; Cortés-Rodríguez, Ana Belén CSIC ORCID; Rodríguez-Aguilera, Juan Carlos CSIC ORCID; Matté, Cristiane; Ribes, Antonia; Prieto-Soler, Sandra Y.; Dominguez-del-Toro, Eduardo; Francesco, Andrea Di; Aon, Miguel A.; Bernier, Michel; Salviati, Leonardo; Artuch, Rafael; Cabo, Rafael de; Jackson, Sandra; Navas, Plácido CSIC ORCID
KeywordsCoenzyme Q deficiency
Mitochondrial diseases
Respiratory chain
Fatty acids
Myopathy
AarF domain-containing mitochondrial protein kinase 2(ADCK2)
Issue Date2019
PublisherMultidisciplinary Digital Publishing Institute
CitationJournal of Clinical Medicine 8(9): 1374 (2019)
AbstractFatty acids and glucose are the main bioenergetic substrates in mammals. Impairment of mitochondrial fatty acid oxidation causes mitochondrial myopathy leading to decreased physical performance. Here, we report that haploinsufficiency of ADCK2, a member of the aarF domain-containing mitochondrial protein kinase family, in human is associated with liver dysfunction and severe mitochondrial myopathy with lipid droplets in skeletal muscle. In order to better understand the etiology of this rare disorder, we generated a heterozygous Adck2 knockout mouse model to perform in vivo and cellular studies using integrated analysis of physiological and omics data (transcriptomics–metabolomics). The data showed that Adck2+/− mice exhibited impaired fatty acid oxidation, liver dysfunction, and mitochondrial myopathy in skeletal muscle resulting in lower physical performance. Significant decrease in Coenzyme Q (CoQ) biosynthesis was observed and supplementation with CoQ partially rescued the phenotype both in the human subject and mouse model. These results indicate that ADCK2 is involved in organismal fatty acid metabolism and in CoQ biosynthesis in skeletal muscle. We propose that patients with isolated myopathies and myopathies involving lipid accumulation be tested for possible ADCK2 defect as they are likely to be responsive to CoQ supplementation.
Description© 2019 by the authors.
Publisher version (URL)http://dx.doi.org/10.3390/jcm8091374
URIhttp://hdl.handle.net/10261/209337
DOI10.3390/jcm8091374
E-ISSN2077-0383
Appears in Collections:(CABD) Artículos




Files in This Item:
File Description SizeFormat
ADCK2_ Vazquez_Fonseca_Art2019.pdf2,25 MBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

PubMed Central
Citations

17
checked on May 3, 2024

SCOPUSTM   
Citations

27
checked on May 15, 2024

WEB OF SCIENCETM
Citations

20
checked on Feb 25, 2024

Page view(s)

222
checked on May 18, 2024

Download(s)

187
checked on May 18, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Related articles:


This item is licensed under a Creative Commons License Creative Commons